Less Ads, More Data, More Tools Register for FREE

Pin to quick pickspolarean Regulatory News (POLX)

  • There is currently no data for POLX

Director dealing

2 Jan 2020 16:50

RNS Number : 6117Y
Polarean Imaging PLC
02 January 2020
 

Polarean Imaging Plc 

("Polarean" or the "Company")

 

Director Dealing

 

Polarean Imaging plc (AIM: POLX), the medical-imaging technology company, with a proprietary drug-device combination product, announces that it was notified on 31 December 2019 that Mr Richard Hullihen, the Company's CEO, has purchased a total of 347,100 ordinary shares of £0.00037 ("Ordinary Shares") via three transactions which are summarised in the table below (the "Transactions").

Date of Transaction

Number of Ordinary Shares purchased

Price per Ordinary Share

13 December 2019

100,000

20.22p

16 December 2019

100,000

20.02p

27 December 2019

147,100

23.87p

 

Following this Transactions, Mr Hullihen holds a beneficial interest in 2,928,899 Ordinary Shares, representing 2.56 per cent. of the Company's issued share capital with voting rights.

 

Enquiries: 

 

Polarean Imaging plc 

www.polarean.com / www.polarean-ir.com 

Richard Hullihen, Chief Executive Officer 

Via Walbrook PR 

Richard Morgan, Chairman 

 

 

 

SP Angel Corporate Finance LLP 

Tel: +44 (0)20 3470 0470  

David Hignell / Soltan Tagiev (Corporate Finance) 

 

Vadim Alexandre / Rob Rees (Corporate Broking)

 

 

Walbrook PR 

Tel: +44 (0)20 7933 8780 or polarean@walbrookpr.com 

Anna Dunphy / Paul McManus 

Mob: +44 (0)7879 741 001 / +44 (0)7980 541 893 

 

Market Abuse Regulation (MAR) Disclosure

Certain information contained in this announcement would have been deemed inside information for the purposes of Article 7 of Regulation (EU) No 596/2014 until the release of this announcement.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:

 

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Mr Richard Hullihen

2.

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Polarean Imaging Plc

b)

LEI:

213800DGR2BHXJ36OL37

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Ordinary shares of £0.00037

GB00BF3DT583

b)

Nature of the transaction:

Purchase of shares

c)

Price(s) and volume(s):

 

Transaction

Price(s)

Volume(s)

(i)

(ii)

(iii)

20.22 pence

20.02 pence

23.87 pence

100,000

100,000

147,100

 

d)

Aggregated information:

Aggregated volume:

Price:

Single transaction as in 4 c) above

Price(s)

Volume(s)

See above

347,100

 

 

 

e)

Date of the transactions:

(i): 13 December 2019

(ii): 16 December 2019

(iii): 27 December 2019

f)

Place of the transactions:

London Stock Exchange, AIM Market

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDZGGMVZNGGZM
Date   Source Headline
19th Jun 20244:10 pmRNSHolding(s) in Company
19th Jun 20244:10 pmRNSHolding(s) in Company
19th Jun 20243:55 pmRNSHolding(s) in Company
19th Jun 20247:00 amRNSHolding(s) in Company
18th Jun 20245:38 pmRNSHolding(s) in Company
18th Jun 20245:37 pmRNSHolding(s) in Company
14th Jun 20242:48 pmRNSResult of GM, Open Offer Update and TVR
23rd May 20247:00 amRNSPosting of Circular
22nd May 20247:00 amRNSResult of Placing
21st May 20244:51 pmRNSProposed Placing, Subscription and Open Offer
10th May 20247:00 amRNSNew Xenon MRI System order received
8th May 20247:00 amRNSXenon MRI to be featured at ATS 2024 conference
3rd May 20247:00 amRNSOrder received for upgraded hyperpolariser
16th Apr 20247:00 amRNSU.S. Patent granted for Xenon MRI
14th Mar 20247:00 amRNSExercise of Warrants, Issue of Equity and TVR
12th Mar 20243:59 pmRNSHolding(s) in Company
29th Feb 20247:00 amRNS2024 Polarean Strategy Update
26th Jan 20247:00 amRNSBlock Listing Six Monthly Return
15th Jan 20247:00 amRNSComment re: share purchase
12th Jan 20245:00 pmRNSHolding(s) in Company
12th Jan 20245:00 pmRNSHolding(s) in Company
7th Dec 20237:00 amRNSCompany Update
27th Nov 20237:00 amRNSHolding(s) in Company
27th Sep 20231:59 pmRNSDirectorate Change
8th Sep 20237:00 amRNSPartnership with VIDA
7th Sep 20234:54 pmRNSHalf-year Report
7th Sep 20237:00 amRNSHalf-year Report
5th Sep 202311:51 amRNSReimbursement code price range for XENOVIEW
29th Aug 20237:00 amRNSCMS grants reimbursement code for XENOVIEW
21st Aug 20235:29 pmRNSHolding(s) in Company
15th Aug 20237:00 amRNSNotice of Results
7th Aug 20237:00 amRNSExercise of Warrants
3rd Aug 20237:00 amRNSClearance received for new MRI chest coil
31st Jul 20237:00 amRNSClinical imaging with XENOVIEW in Missouri
27th Jul 20237:00 amRNSBlock Listing Six Monthly Return
30th Jun 20237:00 amRNSExercise of Warrants
28th Jun 20233:00 pmRNSResult of AGM
21st Jun 20237:00 amRNSAppointment of Dr. Christopher von Jako as new CEO
2nd Jun 20233:00 pmRNSCollaboration with Philips at ISMRM 2023
2nd Jun 20237:00 amRNSExtension of Warrants
26th May 20237:00 amRNSFinal Results
11th May 20232:42 pmRNSFirst clinical scan using XENOVIEW in Cincinnati
3rd May 20235:00 pmRNSFeatured at 2023 ATS Respiratory Innovation Summit
26th Apr 20237:00 amRNSFirst order for XENOVIEW gas blend received
17th Apr 20237:00 amRNSAppointment of Dan Brague as consultant
14th Mar 20237:30 amRNSRestoration - Polarean Imaging PLC
14th Mar 20237:00 amRNSRequest for temporary suspension to be lifted
13th Mar 20237:30 amRNSSuspension - Polarean Imaging PLC
13th Mar 20237:00 amRNSSilicon Valley Bank Relationship
20th Feb 20234:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.